Literature DB >> 6168771

Transformation-defective mutants of Snyder-Theilen feline sarcoma virus lack tyrosine-specific protein kinase activity.

M Barbacid, L Donner, S K Ruscetti, C J Sherr.   

Abstract

Four phenotypically normal mink cell clones, each containing a transformation-defective provirus of the Snyder-Theilen strain of feline sarcoma virus (ST-FeSV), synthesized an 85,000-dalton viral polyprotein (P85) indistinguishable in size and antigenic complexity from that encoded by wild-type transforming ST-FeSV. An additional transformation-defective, ST-FeSV-containing flat cell clone produced a polyprotein of 88,000 daltons (P88). The viral polyproteins immunoprecipitated from cytoplasmic extracts of these cells lacked the tyrosine-specific protein kinase activity associated with the wild-type ST-FeSV gene product. In addition, the products encoded by representative transformation-defective ST-FeSV genomes were poorly phosphorylated in vivo and lacked detectable phosphotyrosine residues. Whereas proteins of ST-FeSV transformants contained elevated levels of phosphotyrosine, those of mink cells containing transformation-defective ST-FeSV exhibited phosphotyrosine levels no higher than those found in uninfected cells. These findings provide genetic evidence that the tyrosine-specific protein kinase activity associated with ST-FeSV P85 is required for virus-induced transformation.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6168771      PMCID: PMC171283          DOI: 10.1128/JVI.39.1.246-254.1981

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  28 in total

1.  Biological properties and translational products of three independent isolates of feline sarcoma virus.

Authors:  K J Porzig; M Barbacid; S A Aaronson
Journal:  Virology       Date:  1979-01-15       Impact factor: 3.616

2.  Different mechanisms for morphologic reversion of a clonal population of murine sarcoma virus-transformed nonproducer cells.

Authors:  W I Bensinger; K C Robbins; J S Greenberger; S A Aaronson
Journal:  Virology       Date:  1977-04       Impact factor: 3.616

3.  Pseudotypes of feline sarcoma virus contain an 85,000-dalton protein with feline oncornavirus-associated cell membrane antigen (FOCMA) activity.

Authors:  C J Sherr; A Sen; G J Todaro; A Sliski; M Essex
Journal:  Proc Natl Acad Sci U S A       Date:  1978-03       Impact factor: 11.205

4.  Protein kinase activity associated with the avian sarcoma virus src gene product.

Authors:  M S Collett; R L Erikson
Journal:  Proc Natl Acad Sci U S A       Date:  1978-04       Impact factor: 11.205

5.  Evidence that the transforming gene of avian sarcoma virus encodes a protein kinase associated with a phosphoprotein.

Authors:  A D Levinson; H Oppermann; L Levintow; H E Varmus; J M Bishop
Journal:  Cell       Date:  1978-10       Impact factor: 41.582

6.  Transformation-defective virus mutants in a class of morphologic revertants of sarcoma virus transformed nonproducer cells.

Authors:  J S Greenberger; G R Anderson; S A Aaronson
Journal:  Cell       Date:  1974-08       Impact factor: 41.582

7.  A film detection method for tritium-labelled proteins and nucleic acids in polyacrylamide gels.

Authors:  W M Bonner; R A Laskey
Journal:  Eur J Biochem       Date:  1974-07-01

8.  Thyrotrophin-releasing hormone and shaking behaviour in rat.

Authors:  E Wei; S Sigel; H Loh; E L Way
Journal:  Nature       Date:  1975-02-27       Impact factor: 49.962

9.  Cellular regulation of mammalian sarcoma virus expression: a gene regulation model for oncogenesis.

Authors:  K J Porzig; K C Robbins; S A Aaronson
Journal:  Cell       Date:  1979-04       Impact factor: 41.582

10.  Feline leukemia virus: biochemical and immunological characterization of gag gene-coded structural proteins.

Authors:  A S Khan; J R Stephenson
Journal:  J Virol       Date:  1977-09       Impact factor: 5.103

View more
  7 in total

1.  Expression of the mammalian c-fes protein in hematopoietic cells and identification of a distinct fes-related protein.

Authors:  I MacDonald; J Levy; T Pawson
Journal:  Mol Cell Biol       Date:  1985-10       Impact factor: 4.272

2.  Mapping of multiple phosphorylation sites within the structural and catalytic domains of the Fujinami avian sarcoma virus transforming protein.

Authors:  G Weinmaster; E Hinze; T Pawson
Journal:  J Virol       Date:  1983-04       Impact factor: 5.103

3.  Revertants and partial transformants of rat fibroblasts infected with Fujinami sarcoma virus.

Authors:  B Mathey-Prevot; M Shibuya; J Samarut; H Hanafusa
Journal:  J Virol       Date:  1984-05       Impact factor: 5.103

4.  McDonough feline sarcoma virus: characterization of the molecularly cloned provirus and its feline oncogene (v-fms).

Authors:  L Donner; L A Fedele; C F Garon; S J Anderson; C J Sherr
Journal:  J Virol       Date:  1982-02       Impact factor: 5.103

5.  Gene products of McDonough feline sarcoma virus have an in vitro-associated protein kinase that phosphorylates tyrosine residues: lack of detection of this enzymatic activity in vivo.

Authors:  M Barbacid; A V Lauver
Journal:  J Virol       Date:  1981-12       Impact factor: 5.103

6.  Mutant feline sarcoma proviruses containing the viral oncogene (v-fes) and either feline or murine control elements.

Authors:  J Even; S J Anderson; A Hampe; F Galibert; D Lowy; G Khoury; C J Sherr
Journal:  J Virol       Date:  1983-03       Impact factor: 5.103

7.  Replacement of lys 622 in the ATP binding domain of P100gag-mil abolishes the in vitro autophosphorylation of the protein and the biological properties of the v-mil oncogene of MH2 virus.

Authors:  F Denhez; B Heimann; L d'Auriol; T Graf; M Coquillaud; J Coll; F Galibert; K Moelling; D Stehelin; J Ghysdael
Journal:  EMBO J       Date:  1988-02       Impact factor: 11.598

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.